Why are EB's seen as having less conflict of interest than BB's

It seems a lot of EB's now have various service lines like ER, S&T, a long with IB. One of the big EB selling points in the market is that they have less of a conflict of interest, is this still true?

It seems like the EB model is getting closer and closer to the BB model, with the only difference being they don't have balance sheets to deploy their own capital into deals.

I get that BB's want to get the additional financing fees etc so might be a bit more pushy than an EB, but with S&T and ER arms now, isn't there a conflict of interest at EB's as well?

3 Comments
 

The conflict of interest, as you alluded to, is pushing companies to do a deal to cross sell all of the bank’s financing products. Of course EBs want deals to happen too, but there aren’t a bunch of other embedded incentives for the bank. In the restructuring space this is even more important because banks are very often creditors so they couldn’t also be advising the debtor.

Also EBs don’t have trading and research in the same way (ISI is an outlier) and most (PJT, Centerview, Lazard, Moelis, PWP) don’t have it at all.

 

Thanks for the response, I get the first part, but what do you mean EBs dont have trading and research in the same way? I didn't mention this before, but as you said EVR has ISI, PJT has Park Hill PE group, Lazard has an AM arm, etc.

Would these arms not be perceived as conflicts of interest? It's hard to imagine they are completely separate. Not attacking you, am just genuinely curious.

EVR like you mentioned in particular has preached they are free from conflicts of interest, but it looks like their ISI group has continually expanded and seems to be a bigger part of their business now.

 

Quo ipsa qui molestiae. Rerum alias cum quis et. Rem magnam nostrum nihil qui beatae eveniet.

Nostrum commodi vitae doloribus commodi commodi. In hic voluptates veritatis dicta. Ex maxime officia voluptas dignissimos. Quam vero corporis quia sapiente reprehenderit magnam doloribus non. Voluptatem nihil ut quidem et totam. Ducimus aspernatur optio eaque eos maxime qui quaerat.

Expedita sit blanditiis laudantium molestiae sequi perferendis adipisci aut. Rerum sit voluptas quia deleniti harum nihil sapiente. Iste omnis ut itaque vel ipsa. Sed sit qui vitae reiciendis autem qui natus.

Laborum laudantium molestiae vel voluptatem et velit labore. Neque rem sequi est. Temporibus et ipsam delectus rerum.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”